Valeant Pharmaceuticals Intl Inc (VRX) – Statement Regarding the Relative Impact of Restating Earnings

HFA Padded
Guest Post
Published on
Updated on
Valeant VRX new CEO

Valeant Pharmaceuticals Intl Inc (VRX) – Statement Regarding the Relative Impact of Restating Earnings by TheSkeptic Recent questions have been raised regarding statements made during Valeant Pharmaceuticals Intl Inc’s Third Quarter Investor Presentation, on October 26, 2015, addressing the relative impact of Philidor on Valean’ts growth.  Here are the facts: On the Investor call, the company provided directional overview of the key elements of the Philidor Program (See Slide #7 of the Investor Presentation, dated October 26, 2015) “Key Elements of the Philidor Program” On the Investor call, in response to our general fear of being singled out and accurately portrayed for what…

This content is exclusively for paying members of Hedge Fund Alpha

Log In

Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha

Don’t have an account?

Subscribe now and get 7 days free!

HFA Padded

If you are interested in contributing to ValueWalk on a regular or one time basis read this post http://www.valuewalk.com/guest-posts-hedge-fund-letters/ We do not accept any outside posts or even ads on penny stocks, ICOs, cryptos, forex, binary options and related products.